Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-CIS: Pedmark as Otoprotectant in Adults Receiving Cisplatin
NCT07407582Phase 2Recruiting
- Sponsor
- University of Arizona
- Start
- May 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium thiosulfate in hearing loss, sponsored by University of Arizona. Started May 2026; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
hearing loss
Beyond the preview
Go deeper on NCT07407582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07407582.